Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial YL Hurd, S Spriggs, J Alishayev, G Winkel, K Gurgov, C Kudrich, ... American Journal of Psychiatry 176 (11), 911-922, 2019 | 294 | 2019 |
The relevance of sex in the association of synthetic cannabinoid use with psychosis and agitation in an inpatient population AB Nia, CL Mann, S Spriggs, DR DeFrancisco, S Carbonaro, L Parvez, ... The Journal of clinical psychiatry 80 (4), 19424, 2019 | 16 | 2019 |
Qualitative analysis of attitudes toward adult-child sexual activity among minor-attracted persons SA Spriggs, LJ Cohen, A Valencia, ZS Yaseen, II Galynker Journal of Sex & Marital Therapy 44 (8), 787-799, 2018 | 11 | 2018 |
Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity CL Gibson, AB Nia, SA Spriggs, D DeFrancisco, A Swift, C Perkel, ... Psychiatry research 293, 113380, 2020 | 8 | 2020 |
Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis A Bassir Nia, CL Gibson, SA Spriggs, SE Jankowski, D DeFrancisco, ... Journal of Psychopharmacology 37 (5), 484-489, 2023 | 2 | 2023 |
" Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial … YL Hurd, S Spriggs, J Alishayev, G Winkel, K Gurgov, C Kudrich, ... American Psychiatric Assn, 2020 | 2 | 2020 |
574. Synthetic Cannabinoid Use in Relation to Psychosis: Evaluation of the Role of Stress and Immune Systems A Bassirnia, S Spriggs, C Perkel, C Tessereau, H Estakhri, A Husain, ... Biological Psychiatry 81 (10), S232, 2017 | 1 | 2017 |
155. Cannabis Use is Associated With Low Plasma Endocannabinoid Anandamide in Individuals With Psychosis AB Nia, C Gibson, S Spriggs, S Jankowskib, D DeFrancisco, A Swift, ... Biological Psychiatry 93 (9), S156-S157, 2023 | | 2023 |
Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis. CL Gibson, SA Spriggs, SE Jankowski, D DeFrancisco, A Swift, C Perkel, ... Journal of Psychopharmacology (Oxford, England), 2698811221148604 …, 2023 | | 2023 |
Higher Levels of Anandamide in Positive History of Trauma and Higher Levels of 2AG in PTSD, in Individuals With Acute Psychosis AB Nia, C Mann, S Spriggs, C Honrao, D DeFrancisco, C Perkel, ... NEUROPSYCHOPHARMACOLOGY 44 (SUPPL 1), 400-401, 2019 | | 2019 |
2273 Synthetic cannabinoid usage among psychiatric inpatients CL Mann, AB Nia, S Spriggs, S Carbonaro, D DeFrancisco, L Parvez, ... Journal of Clinical and Translational Science 2 (S1), 48-48, 2018 | | 2018 |
48 cambridge. org/jcts CL Mann, AB Nia, S Spriggs, S Carbonaro, D DeFrancisco, L Parvez, ... | | |